期刊文献+

慢性阻塞性肺疾病急性加重预警研究进展 被引量:2

Advances in prediction of acute exacerbation of chronic obstructive pulmonary disease
原文传递
导出
摘要 慢性阻塞性肺疾病(COPD)是我国乃至全世界的常见病之一,是目前世界上第4大死亡原因之一,其最主要原因是慢性阻塞性肺疾病急性加重(AECOPD)反复发作,导致住院率增加,造成严重的社会问题和经济负担。但是,目前AECOPD的诊断主要依据临床症状,尚缺乏有效应用于临床的客观指标。本文主要对AECOPD的定义、危险因素及预警研究进展作一综述。 Chronic obstructive pulmonary disease (COPD) is one of the most common diseases in China and the world.It is one of the fourth leading causes of death in the world.The main cause is the acute exacerbation of chronic obstructive pulmonary disease ( AECOPD),which can increase in the rate of hospitalization and can result in serious social and economic burden. However, at present,the diagnosis of COPD acute exacerbation is based on clinical symptoms,and there is still a lack of effective clinical marker.This paper mainly describes the definition,risk factors and predict research progress of AECOPD.
作者 杨慧俐 石新林 王大新 徐兴祥 Yang Huili;Shi Xinlin;Wang Daxin;Xu Xingxiang(Department of Medicine,Dalian Medical University,Dalian 116044,China;Department of Respiratory Medicine,Yangzhou University Medical School,Yangzhou 225001,China;Deparment of Cardiovascular Medicine,Northern Jiangsu People's Hospital,Yangzhou 225001,China;Department of Respiratory Medicine,Northern Jiangsu People's Hospital,Yangzhou 225001,China)
出处 《国际呼吸杂志》 2019年第12期956-960,共5页 International Journal of Respiration
关键词 肺疾病 慢性阻塞性 急性加重 定义 危险因素 预警 Pulmonary disease, chronic obstructive, acute exacerbation Definition, Risk factors Preidiction
  • 相关文献

参考文献2

二级参考文献38

  • 1Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-760.
  • 2Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-471.
  • 3Rothberg MB, Pekow PS, Lahti M, Brody 0, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010; 303: 2035-2042.
  • 4Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196- 204.
  • 5National Committee for Clinical Laboratory Standards. National Committee for Clinical Laboratory Standards, Wayne, Pa. Performance standards for antimicrobial susceptibility testing. 2004; MI00-SI4.
  • 6Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
  • 7Ko FW, Ng TK, Li TS, Fok JP, Chan MC, WuAK, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005; 99: 454-460.
  • 8Hui DS, 1p M, Ling T, Chang SC, Liao CH, Yoo CG, et al. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis. Respirology 20 II; 16: 532-539.
  • 9Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 2355-2365.
  • 10Ko FW, 1p M, Chan PK, Fok JP, Chan MC, Ngai JC, et al. A I-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007; 131: 44-52.

共引文献73

同被引文献12

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部